| Code | CSB-MP025944HU-WD1 |
| Abbreviation | Recombinant Human VTN protein (Active) |
| MSDS | |
| Size | Inquiry |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
Vitronectin mediates cell adhesion, migration, and matrix remodeling through integrin and urokinase plasminogen activator receptor interactions, making it a critical component in wound healing, cancer invasion, and fibrosis models. This full-length mature protein (aa 20–478) demonstrates functional activity with an ED50 of 2–10 μg/mL in supporting NIH3T3 fibroblast adhesion, providing a quantitative benchmark for optimizing cell attachment assays and 3D culture scaffold coatings. Mammalian expression preserves the native glycosylation patterns essential for proper integrin binding, enabling researchers to study physiologically relevant receptor interactions in cancer invasion models and matrix remodeling experiments. The combination of >95% purity and ≤1 EU/mg endotoxin satisfies the quality criteria typical for integrin-binding assays, antibody validation workflows, and primary cell culture applications where low endotoxin levels are critical for maintaining cell viability and preventing inflammatory artifacts.
There are currently no reviews for this product.